• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Intracellular metabolism and mechanism of action of antileukemic agents studied by means of automatic simulation system of drug concentration.

Research Project

Project/Area Number 06671083
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionFukui Medical School

Principal Investigator

UEDA Takanori  Fukui Medical School First Department of internal medicine Professor, 医学部, 教授 (40160171)

Project Period (FY) 1994 – 1996
Keywordsautomatic simulation system / clonogenic assay / ara-C / daunorubicin / cell growth inhibition study / pharmacokinetics
Research Abstract

It is very important to study the metabolism and action of antileukemic agents under the condition which precisely reflect the clinical pharmacokinetics. In this year, we studied cell growth inhibition of leukemic cell line (K562) by cytosine arabinoside (ara-C), using method of trypan blue dye exclusion assay (TB) and clonogenic assay (CA) under the drug concentration regulated by automatic simulation system which was established last year. Under the condition of clinically regular dose ara-C (100mg/m_2) and equal area under the curve (AUC) each other, the cell growth by 2,4,8,16 hour infusion was 73%, 53%, 39%, 45% using TB,and 76%, 72%, 34%, 15% using CA respectively, compared with control. More obvious time dependent inhibition by ara-C was observed using CA.We also compared the effect of daunorubicin (DNR) by simulation method with the data by conventional culture system. The cell growth was 82% of the control using CA under simulated condition with DNR 40mg/m_2 30min.infusion (Cmax ; 0.20 muM,t1/2beta ; 4.35 hr). On the other side, 0.022 muM was required to get the same growth inhibition effect by 24 hours incubation under condition of conventional culture system. About 9 times higher concentration was required in automatic simulation system compared with conventional culture system. This result was different from the the case with the ara-C in last year where the difference was about 80 times, suggesting the difference might depend on the action and metabolism of each drug. In addition, it was suggested that to estimate the anti-tumor effect of drug, automatic simulation system is superior than conventional culture system. And it was also suggested that CA was better method than TB to judge the cell growth inhibition effect. Now we are studying cell growth inhibition under condition to simulate ara-C and DNR simultaneously using automatic simulation system.

  • Research Products

    (42 results)

All Other

All Publications (42 results)

  • [Publications] Tohyama, K.: "Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro : comparison with normal blast cells." Exp. Hematol.22. 539-545 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tohyama, K.: "Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome." Brit. J. Haematol.87. 235-242 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Urasaki, Y.: "Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell line." Jpn. J. Cancer Res.85. 659-664 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawai, Y.: "Modulation of the effect of 1-β-D-arabinofuranosylcytosine by 6-mercaptopurine in L1210 cells." Jpn. J. Cancer Res.85. 978-985 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Liu. Y. P.: "Effect of harringtonine on apoptotic cell death and cell cycle progression in human leukemia HL60 cells." Anticancer Res.14. 1509-1516 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ueda, T.: "Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome." Anticancer Res.14. 2093-2098 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fukushima, T.: "Influence of idarubicinol on the antileukemic effect of idarubicin." Leukemia Res.18. 943-947 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tohyama, K.: "A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages." Brit. J. Haematol.91. 795-799 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 綿谷須賀子: "Cytosine Arabinoside (ara-C)少量療法における薬物動態" 臨床薬理. 26. 439-440 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwasaki, H.: "Quantitative description of morphologic changes effected by antileukemic agents in L1210 leukemia cells." Anticancer Res.,. 15. 133-140 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takauji, R.: "Enhancement of Ca^<2+>-dependent endonuclease activity in L1210 cells during apoptosis induced by 1-β-D-arabinofuranosylcytosine : Possible involvement of activating factor (s)." Jpn. J. Cancer Res.86. 677-684 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岩崎博道: "Cytosine arabinosideおよびdaunorubicinにより誘導されるapoptosisの経時的形態変化." プリン・ピリミジン代謝. 19. 169-176 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 吉田 明: "Endonuclease活性化機構よりみた抗腫瘍剤による白血病細胞のapoptosis." プリン・ピリミジン代謝. 19. 177-179 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamauchi, T.: "A new sensitive method for determination of intracellular 1-β-D-arabinofuranosyl cytosine 5'-triphosphate content in human materials in vivo." Cancer Res.56. 1800-1804 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fukushima, T.: "Superior cytotoxic potency of mitoxantrone in interaction with DNA : Comparison with that of daunorubicin." Oncol. Res.8. 95-100 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Urasaki, Y.: "Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms." Anticancer Res.16. 709-714 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshida, A.: "Role of serine and ICE-like proteases in induction of apoptosis by etoposide in human leukemia HL-60 cells." Leukemia. 10. 821-824 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 上田孝典: "抗白血病薬-新薬と合理的投与法の試み-" 臨床血液. 37. 635-639 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ueda, T.: "Recent developments with novel anthracyclines for the treatment of haematological malignancies." Exp. Opin. Invest. Drugs. 5. 1639-1646 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 上田孝典: "治療研究の新しい展開,抗癌剤の薬物動態と薬理効果(効果と副作用)との関係.図説臨床「癌」シリーズ17白血病・リンパ腫" メジカルビュー社, 274 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 上田孝典: "抗癌剤とアポトーシス.アポトーシスの分子機構と病態" 日本アクセル・シュプリンガー, 126 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tohyama, K.: "Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro : comparison with normal blast cells." Exp.Hematol.22. 539-545 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tohyama, K.: "Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome." Brit.J.Haematol.87. 235-242 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Urasaki, Y.: "Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrugresistant cell line." Jpn.J.Cancer Res.85. 659-664 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kawai, Y.: "Modulation of the effect of 1-beta-D-arabinofuranosylcytosine by 6-mercaptopurine in L1210 cells." Jpn.J.Cancer Res.85. 978-985 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Liu, Y.P.: "Effect of harringtonine on apoptotic cell death and cell cycle progression in human leukemia HL60 cells." Anticancer Res.14. 1509-1516 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueda, T.: "Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome." Anticancer Res.14. 2093-2098 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fukushima, T.: "Influence of idarubicinol on the antileukemic effect of idarubicin." Leukemia Res.18. 943-947 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Thyama.K.: "A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages." Brit.J.Haematol.91. 795-799 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wataya, S.: "Pharmacokinetics of low-dose cytosine arabinoside (ara-C)." Jpn.J.Clin.Pharmacol.Ther.26. 439-440 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwasaki, H.: "Quantitative description of morphologic changes effected by antileukemic agents in L1210 leukemia cells." Anticancer Res.15. 133-140 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takauji, R.: "Enhancement of Ca^<2+>-dependent endonuclease activity in L1210 cells during apoptosis induced by 1-beta-D-arabinofuranosylcytosine : Possible involvement of activating factor (s)." Jpn.J.Cancer Res.86. 677-684 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwasaki, H.: "Morphological differences in apoptotic change induced by cytosine arabinoside and daunorubicin." Purine and Pyrimidine Metabolism. 19. 169-176 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshida, A.: "Apoptosis of leukemic cells induced by anticancer agents from the viewpoint of endonuclease activation mechanism." Purine and Pyrimidine Metabolism. 19. 177-179 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamauchi, T.: "A new sensitive method for determination of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate content in human materials in vivo." Cancer Res.56. 1800-1804 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fukushima, T.: "Superior cytotoxic potency of mitoxantrone in interaction with DNA : Comparison with that of daunorubicin." Oncol.Res.8. 95-100 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Urasaki, Y.: "Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms." Anticancer Res.16. 709-714 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshida, A.: "Role of serine and ICE-like proteases in induction of apoptosis by etoposide in human leukemia HL-60 cells." Leukemia. 10. 821-824 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueda, T.: "Antileukemic agents-new drugs and rational methods for administration." Rinsho Ketsueki. 37. 635-639 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueda, T.: "Recent developments with novel anthracyclines for the treatment of haematological malignancies." Exp.Opin.Invest.Drugs. 5. 1639-1646 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueda, T.: Relationship between pharmacokinetics and pharmacodynamics of anticancer agents (the effects and adverse effects). Illustrated clinical series of "cancer" Vol.17, Leukemia and lymphoma. Medical View, 274 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueda, T.: Anticancer agents and apoptosis, Molecular mechanism and pathology of apoptosis. Axl Springer Japan Publishing Inc., 126 (1996)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi